NAC, as a crucial therapeutic approach for breast cancer patients, is indicated for those with locally advanced breast cancer, patients requiring tumor downstaging to enable surgery or breast-conserving surgery, individuals with triple-negative or HER2-positive breast cancer, and those at risk of metastasis (4, 22, 23). The gene discussed is ERBB2; the disease is breast cancer.